Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray clinical trials
How each study uses Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 1 May 2012 · DYMISTA · NDA 202236 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
MEDA Pharma GmbH & Co. KG (1) · Padagis LLC (1) · Meda Pharmaceuticals (1) · University of Dundee (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- DYmista NAsal Spray in CHInese PatientsCompletedPhase 3MEDA Pharma GmbH & Co. KGNCT03599791Written as Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT
- Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic RhinitisCompletedPhase 3Padagis LLCNCT02230696Written as Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray
- Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic RhinitisTerminatedPhase 4University of DundeeNCT02953106Written as Azelastine-Fluticasone Nasal
- 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedPhase 3Meda PharmaceuticalsNCT01794741Written as Dymista Nasal Spray
As the comparator · 5 — what is tested is compared with Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray
- Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)Not yet recruitingPhase 3EMSNCT05684380Written as DYMISTA®
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic RhinitisCompletedPhase 2Synmosa Biopharma Corp.NCT06051786Written as Dymista™
- Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedPhase 2Glenmark Pharmaceuticals Ltd. IndiaNCT03444506Written as DYMISTA nasal spray
- A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic RhinitisStatus unknownPhase 2Apotex Inc.NCT02279563Written as Dymista™ Nasal Spray
- Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownPhase 3Teva Pharmaceuticals USANCT02249663Written as Dymista™